Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.1007/s00784-020-03214-7
Twittear
Título: | Salivary biomarkers in Alzheimer’s disease |
Fecha de publicación: | 27-ene-2020 |
Editorial: | Springer |
Cita bibliográfica: | Clinical Oral Investigations (2020) 24:3437–3444 Oral Investigations (2020) 24:3437–3444 |
ISSN: | Print: 1432-6981 Electronic: 1436-3771 |
Palabras clave: | Complement Dementia Saliva Amyloid-β Tau |
Resumen: | Objectives The objective of this study was to evaluate the changes that can occur in saliva components in patients with Alzheimer’s disease (AD) of different severity and determine if any of these components could be a biomarker of this disease. Therefore, a panel of selected analytes related to the amyloid cascade, the immune and adrenergic systems, among others, were analyzed in the saliva of patients with Alzheimer’s disease. Methods A total of 152 patients with AD and controls were included. The severity of the disease was established according to the Global Deterioration Scale. Unstimulated whole saliva was collected. Results Salivary amyloid-β42 was significantly lower, and complement C4 was significantly higher in the patients with AD than in the controls (p < 0.05 in both cases). Only complement C4 maintained its significant effect in the multivariate regression analysis. However, the area under the receiver operating characteristic curve of C4 was 0.613. No changes were found in any analyte regarding the severity of the disease. Conclusions A decrease in amyloid-β42 and an increase in complement C4 were detected in the saliva of patients with AD, but the changes did not show a high diagnostic performance for the detection of AD and were not associated with its severity. Clinical relevance Although some analytes showed significant differences in saliva in patients with AD, in our study conditions the salivary biomarkers analyzed were not of enough diagnostic utility for being used in routine |
Autor/es principal/es: | Tvarijonaviciute, Asta Zamora, Carmen Ceron, Jose Bravo-Cantero, Antonio Pardo-Marin, Luis Valverde, Sandra Lopez Jornet, Pia |
Facultad/Departamentos/Servicios: | Facultad de Medicina Estomatologia - Facultad de veterinaria Interlab UMU Facultades, Departamentos, Servicios y Escuelas::Departamentos de la UMU::Dermatología, Estomatología, Radiología y Medicina Física |
Versión del editor: | https://link.springer.com/article/10.1007/s00784-020-03214-7 |
URI: | http://hdl.handle.net/10201/137777 |
DOI: | https://doi.org/10.1007/s00784-020-03214-7 |
Tipo de documento: | info:eu-repo/semantics/article |
Número páginas / Extensión: | 8 |
Derechos: | info:eu-repo/semantics/embargoedAccess |
Descripción: | ©2020. The authors. This document is the published version of a published work that appeared in final form in Clinical Oral Investigations. To access the final edited and published work see https://doi.org/10.1007/s00784-020-03214-7 |
Aparece en las colecciones: | Artículos: Dermatología, Estomatología, Radiología y Medicina Física |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
ALZEIMER.pdf | 417,23 kB | Adobe PDF | Visualizar/Abrir Solicitar una copia |
Los ítems de Digitum están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.